Understanding the genetic basis of neurological conditions is crucial for early detection and implementation of personalized treatment strategies. Genetic testing services use next-generation sequencing technology to analyze genes associated with conditions such as Alzheimer's disease, Parkinson's disease, and other neurodegenerative diseases.
In addition, we designed a panel of tests based on existing knowledge about brain health in general. This enables us to identify specific genetic predispositions and mutations, helping patients understand their risk and enabling early, targeted interventions.
This analysis is carried out in collaboration with genetic diagnostic centers in Greece and abroad.